Sodium Valproate in The Prophylactic Treatment of Migraine: A Double-Blind Study Versus Placebo
- 1 April 1992
- journal article
- research article
- Published by SAGE Publications in Cephalalgia
- Vol. 12 (2) , 81-84
- https://doi.org/10.1046/j.1468-2982.1992.1202081.x
Abstract
The efficacy of sodium valproate (Depalept) versus placebo in the treatment of migraine was evaluated in a double-blind randomized cross-over study in twenty-nine patients. The patients were divided into two groups each of which was alternately given 400 mg of sodium valproate B.I.d or placebo for eight weeks and then crossed over for an additional eight weeks. Our results show that in 86.2% of the patients sodium valproate was effective in preventing migraine or reducing the frequency, severity and duration of the attacks. In general, the drug was well tolerated and proved to be an effective treatment in migraine.Keywords
This publication has 23 references indexed in Scilit:
- Loss of a circadian adrenal corticosterone rhythm following suprachiasmatic lesions in the ratPublished by Elsevier ,2003
- Valproate in the Treatment of Persistent Chronic Daily Headache. An Open Label StudyHeadache: The Journal of Head and Face Pain, 1991
- Valproate: a new drug in migraine prophylaxisActa Neurologica Scandinavica, 1988
- Effect of γ-Aminobutyric Acid (GABA) on Vasodilation in Resistance-Sized Arteries Isolated from the Monkey, Rabbit, and RatJournal of Cardiovascular Pharmacology, 1988
- Increased prolactin response to thyrotropin releasing hormone during migraine attacks.Journal of Neurology, Neurosurgery & Psychiatry, 1987
- Letter to the EditorHeadache: The Journal of Head and Face Pain, 1987
- GABAergic control of anterior pituitary hormone secretionLife Sciences, 1982
- L‐Dopa Effect on Prolactin Plasma Levels in Complicated and Common Migrainous PatientsHeadache: The Journal of Head and Face Pain, 1981
- PROLACTIN, LEVODOPA, AND MIGRAINEThe Lancet, 1975
- PREVENTION OF MIGRAINE BY REDUCING PROLACTIN LEVELS ?The Lancet, 1973